Table 3.

Age- and sex-stratified two-year prevalence of HD

	Women (n = 139)			95%-CI	Men (n = 169)			95%-CI	All (n = 308)			95%-CI
	N population	n cases	Prevalence per 100,000 persons		N population	n cases	Prevalence per 100,000 persons		N population	n cases	Prevalence per 100,000 persons
Age
0–29 years	426,131	< 5	–		440,649	/	–		866,780	6	0.7	0.3–1.5
30–39 years	173,714	5	2.9	1.2–6.7	172,856	10	5.8	3.1–10.6	346,570	15	4.3	2.6–7.1
40–49 years	221,720	18	8.1	5.1–12.8	223,105	29	13.0	9.1–18.7	444,825	47	10.6	7.9–14.0
50–59 years	284,651	38	13.3	9.7–18.3	289,813	48	16.6	12.5–22.0	574,464	86	15.0	12.1–18.5
60–69 years	235,666	42	17.8	13.2–24.1	222,871	35	15.7	11.3–21.8	458,537	77	16.8	13.4–21.0
70–79 years	193,336	24	12.4	8.3–18.5	192,799	34	17.6	12.6–24.6	386,135	58	15.0	11.6–19.4
> =80 years	141,035	9	6.4	3.4–12.1	107,292	10	9.3	5.1–17.2	248,327	19	7.7	4.9–12.0
All	1,676,253	139	8.3	7.0–9.8	1,649,385	169	10.2	8.8–11.9	3,325,638	308	9.3	8.3–10.4

CI Confidence interval